Table 2 Predictors of inhaled corticosteroid prescription in the neonatal intensive care unit.
Unadjusted OR (95% CI) | Adjusted OR (95% CI) | |
|---|---|---|
Risk factors: | ||
Gestational age | ||
<25 weeks | 18.72 (17.47–20.06) | 1.66 (1.48–1.87) |
26–28 weeks | 5.31 (4.97–5.66) | 1.69 (1.54–1.85) |
29–32 weeks | ref | Ref |
Male sex | 1.30 (1.25–1.36) | 1.16 (1.09–1.24) |
Race/ethnicity | ||
White | ref | ref |
Black | 1.14 (1.08–1.20) | 0.99 (0.91–1.08) |
Hispanic | 0.97 (0.91–1.03) | 0.93 (0.84–1.03) |
Other | 0.99 (0.90–1.09) | 0.86 (0.75–0.99) |
BPD | 9.23 (8.79–9.69) | 2.50 (2.27–2.75) |
Antenatal steroid use | 1.07 (0.99–1.14) | 1.29 (1.16–1.44) |
Mechanical ventilation (weeks) | 1.47 (1.46–1.48) | 1.02 (1.00–1.04) |
Oxygen support (weeks) | 1.24 (1.23–1.24) | 1.22 (1.20–1.23) |
Systemic steroid use (weeks) | 1.41 (1.39–1.43) | 1.08 (1.06–1.10) |